New target antigen could make CAR-T possible for glioblastomas – FierceBiotech
FierceBiotech |
New target antigen could make CAR–T possible for glioblastomas
FierceBiotech Surgery, radiation and chemotherapy just don't cut it against glioblastoma, a type of aggressive brain tumor with a dismal five-year survival rate. Survival is highest in younger people, at 19% for those aged 20 to 44, but it drops sharply with age … |
